Thomas hesterkamp
WebThomas Hesterkamp2, Mathias Winterhalter29, Andrea Schiefer2,30, Kenneth Pfarr2,30, Achim Hoerauf 2,30 , Heather Graz 31 , Michael Graz 32 , Mika Lindvall 33 , Savithri Ramurthy 34 , Anders Karlén 35 , Maarten van Dongen 36 , Hrvoje Petković 37 , Andreas Keller 38 , Frédéric Peyrane 39 , WebThomas Hesterkamp Andreas Scheel The ever increasing need for improved process efficiency in pharmaceutical drug discovery is a major driving force for assay …
Thomas hesterkamp
Did you know?
WebMar 29, 2012 · Pierre E. Ilouga and Thomas Hesterkamp. Journal of Biomolecular Screening 2012 17: 6, 705-712 Download Citation. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. WebThomas Hesterkamp's 15 research works with 375 citations and 4,966 reads, including: Fighting antibiotic resistance—strategies and (pre)clinical developments to find new …
WebDec 3, 2024 · Plasmodium vivax is a widespread cause of malaria in Mauritania, particularly in the Saharan zone. Analysis of a genome-wide panel of single nucleotide polymorphisms reveals the Mauritanian P. vivax population to be genetically diverse and divergent from parasites elsewhere. The parasites apparently undergo frequent recombination, there is … WebTSV Bonn rrh. - Handballabteilung. HVM/nuLiga Spielplan 2024/23; Kreis B/E/S 2024/23; 1. Herren- Regionalliga Nordrhein 2024/23
WebBalansky J, Pfarr K, Szekat C, Kehraus S, Aden T, Grosse M, Jansen R, Hesterkamp T, Schiefer A, König GM, Stadler M, Hoerauf A, Bierbaum G. 2024. The RNA polymerase inhibitor corallopyronin A has a lower frequency of resistance than rifampicin in Staphylococcus aureus. Antibiotics 11:920. doi: 10.3390/antibiotics11070920. WebJul 8, 2024 · Corallopyronin A (CorA) is active against Gram-positive bacteria and targets the switch region of RNA polymerase. Because of the high frequency of mutation (FoM) leading to rifampicin resistance, we determined the CorA FoM in S. aureus using fluctuation analysis at 4 × minimum inhibitory concentration (MIC). Resistant mutants were …
WebThomas Hesterkamp: Firma Evotec AG Email: [email protected]: Damon Huber: Institute for Microbiology and Infection School of Biosciences University of Birmingham Email: [email protected]: Jocelyne Fiaux Vogel: Novartis Pharma AG, Werk Klybeck, Basel: Anja Hoffmann: Boehringer Ingelheim Fonds
WebNov 1, 2008 · Thomas Hesterkamp. Pharmaceutical Technology Europe. Pharmaceutical Technology Europe, Pharmaceutical Technology Europe-11-01-2008, Volume 20, Issue 11. High-throughput screening (HTS) of compound libraries is the most widely adopted approach to hit discovery because it is the only generic way of addressing a variety of … crossover has killed another handsome sedanWebTranslational infection research and development at DZIF (German Center for Infection Research), section Product Development. Diverse indication … build 150630 rel.34713WebAug 2015 - Apr 20242 years 9 months. 3800 Victory Parkway, Cincinnati, OH, 45207. Responsible for the maintenance and updating of 1000+ alumni … build 15WebI agree that my name and my e-mail-address may be processed to send the newsletter. I have read and accept the Privacy Policy. build 1500 gmcWebMar 1, 2024 · We thank the MVA-MERS-S study group members for their ongoing support and dedication: Etienne Bartels (Institute for Infection Research and Vaccine Development UKE [IIRVD]), German Centre for Infection Research [DZIF]), Monika Friedrich, Swantje Gundlach (IIRVD and DZIF), Thomas Hesterkamp (DZIF), Verena Krähling (Philipps … build 1497.2WebDr. Thomas Hesterkamp. Helmholtz Centre for Infection Research. Head of TPMO: Drug Development. Send mail. CARB-X globally accelerates projects, which develop new drugs … crossover harry potterWebJan 1, 2010 · Hesterkamp T. Author information. Affiliations. All authors. 1. Evotec (UK) Ltd, 114 Milton Park, Abingdon, Oxfordshire OX14 4SA, United Kingdom. ... Cheng, 1 Brunella … build 14 mhz transmitter